Drugplain

Sungboon Editor Daily Invisible Blurring Sunscreen 29 mg/mL

Avobenzone, Homosalate, Octisalate, Octocrylene · CREAM · Olive International Inc.

No Recall History
Plain English

Sungboon Editor Daily Invisible Blurring Sunscreen is a cream containing avobenzone, homosalate, octisalate, octocrylene at 29 mg/mL, taken topical. Manufactured by Olive International Inc..

Key Facts

Brand Name
Sungboon Editor Daily Invisible Blurring Sunscreen
Generic Name
Avobenzone, Homosalate, Octisalate, Octocrylene
NDC Code (Product)
85037-002
Manufacturer
Olive International Inc.
Strength
29 mg/mL
Dosage Form
CREAM
Route
TOPICAL
Marketing Status
Application #
M020
Marketing Start
03/25/2025

Recall History

No Recall History

Frequently Asked Questions

What is Sungboon Editor Daily Invisible Blurring Sunscreen used for?

Sungboon Editor Daily Invisible Blurring Sunscreen contains Avobenzone, Homosalate, Octisalate, Octocrylene. It is a cream taken topical. Consult your doctor for specific uses.

Is Sungboon Editor Daily Invisible Blurring Sunscreen a controlled substance?

Sungboon Editor Daily Invisible Blurring Sunscreen is not classified as a controlled substance by the DEA.

What is the generic name for Sungboon Editor Daily Invisible Blurring Sunscreen?

The generic name for Sungboon Editor Daily Invisible Blurring Sunscreen is Avobenzone, Homosalate, Octisalate, Octocrylene. There are 12 other brand versions of Avobenzone, Homosalate, Octisalate, Octocrylene.

What is the NDC code for Sungboon Editor Daily Invisible Blurring Sunscreen 29 mg/mL?

The NDC (National Drug Code) for Sungboon Editor Daily Invisible Blurring Sunscreen 29 mg/mL is 85037-002, listed by Olive International Inc..